Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee

Boehringer Ingelheim

Status and phase: Completed; Phase 4

Conditions: Osteoarthritis

Treatments: Drug: Diclofenac; Drug: Meloxicam

Study type: Interventional

Funder types: Industry

Identifiers

NCT02183129

107.229

Details and patient eligibility

About

To assess the efficacy and safety of meloxicam 7.5mg once daily compared with diclofenac 100mg SR once daily over a treatment period of 8 weeks

Enrollment: 91 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Osteoarthritis of the knee requiring the therapy with non-steroidal anti-inflammatory drugs (NSAIDs)

Exclusion criteria

• none

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

91 participants in 2 patient groups

Meloxicam

Experimental group

Treatment:

Drug: Meloxicam

Diclofenac

Active Comparator group

Treatment:

Drug: Diclofenac